Joined Today: 14

APPA AP Pharma, Stock Message Board

All Messages

APPA Message Board Home | Join The APPA Group |

#26: A.P. Pharma Announces Stock Option Grant
TheMachine	July 21, 2008 07:21:07 AM
A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceuticals company, announced today it has made a stock option grant to Ronald J. Prentki, who joined the company on... view message ignore post recommend post

#25: A.P. Pharma Appoints Ronald J. Prentki as President, Chief Executive Officer and Member of Its Board of Directors
TheMachine	July 21, 2008 07:20:41 AM
A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, has appointed Ronald J. Prentki as President, Chief Executive Officer and a member of the company’s... view message ignore post recommend post

#24: A.P. Pharma Announces Chief Executive Officer Succession Plan
NewsBot	December 22, 2007 05:04:53 AM
A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceuticals company, today announced that its board of directors has initiated an executive succession program designed to recruit... view message ignore post recommend post

#23: APPA News A.P. Pharma Reports Results for the Fourth Quarter and Full Year 2006; Reports on Progress of APF530 Program
NewsBot	March 7, 2007 01:00:00 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today reported financial results for its fourth quarter and full year ended... view message ignore post recommend post

#22: APPA News A.P. Pharma to Hold 2006 Fourth Quarter Financial Results Conference Call March 7
NewsBot	February 28, 2007 01:00:00 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, will release its 2006 fourth quarter and year end financial results before... view message ignore post recommend post

#21: APPA News Dutton Associates Announces Investment Opinion: AP Pharma Strong Speculative Buy In Update By Dutton Associates
NewsBot	January 10, 2007 09:00:00 AM
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage of AP Pharma (Nasdaq:APPA) with an upgrade of its rating to Strong Speculative Buy. The 10-page report ... view message ignore post recommend post

#20: APPA News A.P. Pharma Resets APF530 NDA Filing Expectations
NewsBot	December 21, 2006 01:00:00 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, reported today that it believes that it will not meet a previously... view message ignore post recommend post

#19: APPA News A.P. Pharma Names New Vice President of Clinical Development
NewsBot	November 20, 2006 10:09:00 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced that Anastassios D. Retzios, Ph.D. has joined the Company... view message ignore post recommend post

#18: APPA News A.P. Pharma Reports 2006 Third Quarter Results
NewsBot	November 7, 2006 01:00:00 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today reported financial results for the three months ended September 30,... view message ignore post recommend post

#17: APPA News A.P. Pharma to Hold 2006 Third Quarter Financial Results Conference Call November 7
NewsBot	October 31, 2006 01:00:00 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, will release its 2006 third quarter financial results before the market... view message ignore post recommend post

#16: APPA News A.P. Pharma Licenses APF530 to RHEI Pharmaceuticals for Development in Greater China
NewsBot	October 2, 2006 01:00:00 AM
REDWOOD CITY, Calif. & NEW HAVEN, Conn.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA) and RHEI Pharmaceuticals, Inc. today announced that A.P. Pharma has granted an exclusive license to... view message ignore post recommend post

#15: APPA News A.P. Pharma Expects Data from APF530 Pivotal Trial in Second Half of 2007
NewsBot	September 28, 2006 01:04:00 PM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced that it expects to have initial data from its Phase 3... view message ignore post recommend post

#14: APPA News A.P. Pharma to Present at Merriman Curhan Ford ''Investor Summit 2006'' on September 18
NewsBot	September 12, 2006 12:27:00 PM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Sept. 12, 2006--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced it will present at the Merriman Curhan Ford "Investor... view message ignore post recommend post

#13: APPA News A.P. Pharma Names Arthur Taylor to Board of Directors
NewsBot	August 14, 2006 01:00:00 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Aug. 14, 2006--A.P. Pharma, Inc. (NASDAQ:APPA), a specialty pharmaceutical company, today announced that Arthur T. Taylor has joined the Company's board of... view message ignore post recommend post

#12: APPA News A.P. Pharma Reports 2006 Second Quarter Results; Phase 3 Clinical Trial for APF530 Underway
NewsBot	August 8, 2006 01:00:00 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Aug. 8, 2006--A.P. Pharma, Inc. (Nasdaq:APPA), a specialty pharmaceutical company, today reported financial results for the three months ended June 30, 2006.... view message ignore post recommend post

Group Home | Login if you want to post a message